Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/37094
Title: Evaluation of antioxidant and anticancer effects of Thymbra sintenisii subsp. isaurica extract
Authors: Hepokur, C.
Misir, S.
Çiçek, Mehmet
Yaylim, I.
Zeybek, U.
Keywords: Antioxidant
apoptosis
cancer
Thymbra sintenisii subsp. isaurica
antineoplastic agent
antioxidant
ascorbic acid
cisplatin
phytochemical
plant extract
polyphenol
Thymbra sintenisii subsp. isaurica extract
unclassified drug
antineoplastic activity
antioxidant activity
Article
cell growth
cell viability
concentration (parameter)
controlled study
DPPH radical scavenging assay
drug cytotoxicity
drug design
drug efficacy
endemic species
flow cytometry
human
human cell
IC50
Lamiaceae
mass fragmentography
MCF-7 cell line
NCTC clone 929 cell line
plant leaf
breast tumor
cell survival
chemistry
drug effect
female
metabolism
Antioxidants
Breast Neoplasms
Cell Survival
Female
Humans
MCF-7 Cells
Plant Extracts
Plant Leaves
Polyphenols
Publisher: Wolters Kluwer Medknow Publications
Abstract: Background: The purpose of this study was to investigate the phenolic composition and antioxidant activity of Thymbra sintenisii subsp. isaurica extract (TSIE) and, to evaluate, for the first time, anticancer effect on human MCF-7 (breast carcinoma) cells. Materials and Methods: The antioxidant capacity of TSIE was evaluated using 2,2-diphenyl-1-picrylhydrazyl (DPPH) and total polyphenol assays. The anticancer activities of TSIE were tested on MCF-7 (breast carcinoma) cells. Results: Total polyphenol value of extracts TSIE was found as 73.02 mg gallic acid /g powder. DPPH result of IC50 value of TSIE was found to be 27.15 µg/mL. To examine anticancer effect of TSIE at different concentrations were given on MCF-7 cells. TSIE was observed to reduce the cell viability in a dose-dependent manner. This anticancer property of the TSIE provides a highlights the importance of plant research for drug design. Conclusion: In this study, anticancer effects and antioxidant level of endemic species, that is TSIE, are evaluated on MCF-7 cells. Thus, an effective therapeutic agent for cancer treatment is aimed to develop. Further studies are needed to better understand the molecular mechanisms underlying this effect of TSIE. © 2020 Wolters Kluwer Medknow Publications. All rights reserved.
URI: https://hdl.handle.net/11499/37094
https://doi.org/10.4103/jcrt.JCRT_355_17
ISSN: 0973-1482
Appears in Collections:Fen-Edebiyat Fakültesi Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record



CORE Recommender

SCOPUSTM   
Citations

2
checked on Jun 29, 2024

WEB OF SCIENCETM
Citations

1
checked on Jul 10, 2024

Page view(s)

48
checked on May 27, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.